Response to Crizotinib in a Lung Adenocarcinoma Patient Harbouring EML4-ALK Transtocation with Adnexal Metastasis

被引：0
|
作者：
Wang, Wenxian [1 ]
Jin, Ying [1 ]
Zhang, Yiping [1 ]
机构：
[1] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Ovarian metastasis; non-small cell lung cancer; ALK; Crizotinib;
D O I：
10.1016/j.jtho.2016.11.1654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02a-024
引用
收藏
页码：S1176 / S1176
页数：1
相关论文
共 50 条
  • [1] Response to crizotinib in a lung adenocarcinoma patient harboring EML4-ALK translocation with adnexal metastasis A Case Report
    Wang, Wenxian
    Wu, Wei
    Zhang, Yiping
    [J]. MEDICINE, 2016, 95 (30)
  • [2] Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report
    Ali, Greta
    Chella, Antonio
    Lupi, Cristiana
    Proietti, Agnese
    Niccoli, Cristina
    Boldrini, Laura
    Davini, Federico
    Mussi, Alfredo
    Fontanini, Gabriella
    [J]. ONCOLOGY LETTERS, 2015, 9 (04) : 1537 - 1540
  • [3] Coexistence of a Novel PRKCB-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient and Response to Crizotinib
    Luo, Jing
    Gu, Dejian
    Lu, Huasong
    Liu, Si
    Kong, Jinliang
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (12) : E266 - E268
  • [4] Crizotinib for EML4-ALK positive lung adenocarcinoma: a hope for the advanced disease?
    Antoniu, Sabina Antonela
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (03) : 351 - 353
  • [5] Alectinib treatment response in lung adenocarcinoma patient with novel EML4-ALK variant
    Song, Peng
    Zhang, Jingcheng
    Shang, Congcong
    Zhang, Li
    [J]. THORACIC CANCER, 2018, 9 (10) : 1327 - 1332
  • [6] A CASE OF LUNG ADENOCARCINOMA HARBORING BOTH A KRAS MUTATION AND AN EML4-ALK FUSION GENE WITH RESPONSE TO CRIZOTINIB
    Menefee, Michael E.
    D'Amico, Thomas A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1315 - S1316
  • [7] Ineffectiveness of Crizotinib on Brain Metastases in Two Cases of Lung Adenocarcinoma with EML4-ALK Rearrangement
    Maillet, Denis
    Martel-Lafay, Isabelle
    Arpin, Dominique
    Perol, Maurice
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (04) : E30 - E31
  • [8] A rare double ALK fusion variant EML4-ALK and CDK15-ALK in lung adenocarcinoma and response to crizotinib A case report
    Guo, Jun
    Shi, Junping
    Yao, Ming
    Jin, Yi
    Liu, Dengxiang
    Liu, Weiling
    Wang, Kai
    Jiang, Da
    [J]. MEDICINE, 2020, 99 (45) : E22631
  • [9] A CASE OF LUNG ADENOCARCINOMA RESISTANT TO CRIZOTINIB HARBORING KRAS MUTATION AND EML4-ALK FUSION GENE
    Anai, Satoshi
    Suzuki, Kunihiro
    Sueishi, Katsuo
    Harada, Taishi
    Toyokawa, Gouji
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Takayama, Koichi
    Ichinose, Yukito
    Nakanishi, Yoichi
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [10] EML4-ALK FUSION GENE IN LUNG ADENOCARCINOMA IN THAILAND
    Prempree, Thongbliew
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1023 - S1024
12345